Angiotensinogen genotype and plasma volume in nulligravid women

Obstetrics and Gynecology

Volumn 92, Issue 2, 1998, Pages 171-173

  Bernstein, Ira M ^a   Ziegler, William ^b   Stirewalt, William S ^b   Brumsted, John ^b   Ward, Ken ^b  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; FETUS GROWTH; GENOTYPE; GROWTH REGULATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MENSTRUAL CYCLE; PLASMA VOLUME; PREECLAMPSIA; PRIORITY JOURNAL;

ANGIOTENSINOGEN; FEMALE; HUMANS; PARITY; PLASMA VOLUME;

EID: 0032146108     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00206-3     Document Type: Article

References (12)

1. 1. Tortora GJ, Grabowski SR. Principles of anatomy and physiology. 8th ed. Scranton, Pennsylvania: HarperCollins, 1996.
2. 2. Jeunemaitre X, Soubier F, Kotelevtsevy V, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-80.
3. 3. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59-61.
4. 4. Gallery EDM, Hunyor SN, Gyory AZ. Plasma volume contraction: A significant factor in both pregnancy associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. QJM 1979;48:593-602.
5. 5. Soffronoff EC, Kaufmann BM, Connaughton JF. Intravascular volume determinations and fetal outcomes in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1977;127:4-9.
6. 6. El-Sayed H, Goodal SR, Hainsworth R. Re-evaluation of Evans blue dye dilution method of plasma volume measurement. Clin Lab Haematol 1995;17:189-94.
7. 7. Ituro I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;9:1786-97.
8. 8. Greenleaf JE, Convertino VA, Mangseth GR. Plasma volume during stress in man: Osmolality and red cell volume. J Appl Physiol 1979;47:1031-8.
9. 9. Croall J, Sherrif S, Matthews J. Non-pregnant maternal plasma volume and fetal growth retardation. Br J Obstet Gynaecol 1978; 85:90-5.
10. 10. Salas SP, Rosso P, Espinoza R, Robert JA, Valdes G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol 1993;81:1029-33.
11. 11. Duvekot JJ, Cheriex EC, Pieters FAA, Menherre PPCA, Schouten HJA, Peeters LLH. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet Gynecol 1995;85:361-7.
12. 12. Clapp JF, Capeless EL. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997;80:1469-73.